Review



proc mixed procedure from the sas software version 9.1  (SAS institute)


Bioz Verified Symbol SAS institute is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SAS institute proc mixed procedure from the sas software version 9.1
    Proc Mixed Procedure From The Sas Software Version 9.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mixed+procedure+from+sas+%28proc+mixed%29/pmc03281313-79-14-16?v=SAS+institute
    Average 90 stars, based on 1 article reviews
    proc mixed procedure from the sas software version 9.1 - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    proc mixed procedure from the sas software version 9.1  (SAS institute)
    90
    SAS institute proc mixed procedure from the sas software version 9.1
    Proc Mixed Procedure From The Sas Software Version 9.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mixed+procedure+from+sas+%28proc+mixed%29/pmc03281313-79-14-16?v=SAS+institute
    Average 90 stars, based on 1 article reviews
    proc mixed procedure from the sas software version 9.1 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    mixed procedure from sas (proc mixed)  (SAS institute)
    90
    SAS institute mixed procedure from sas (proc mixed)
    Mixed Procedure From Sas (Proc Mixed), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mixed+procedure+from+sas+%28proc+mixed%29/pm33743452-69-0-31?v=SAS+institute
    Average 90 stars, based on 1 article reviews
    mixed procedure from sas (proc mixed) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    mixed procedure (proc mixed) from sas software  (SAS institute)
    90
    SAS institute mixed procedure (proc mixed) from sas software
    Mixed Procedure (Proc Mixed) From Sas Software, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mixed+procedure+from+sas+%28proc+mixed%29/pmc06331537-62-20-24?v=SAS+institute
    Average 90 stars, based on 1 article reviews
    mixed procedure (proc mixed) from sas software - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    proc mixed procedure with repeated statement from sas version 9.1.3  (SAS institute)
    90
    SAS institute proc mixed procedure with repeated statement from sas version 9.1.3
    HbA1c over time. (A) Two-year completer population, observed mean values, no imputation. (B) Intention-to-treat (ITT) population, observed mean values, no imputation. (C) ITT population, estimated least square (LS) mean values derived from an analysis of covariance ( <t>ancova</t> ) model with repeated measures. (D) Two-year completer population, participants previously treated with diet and exercise, observed mean values, no imputation. Error bars are ±2s.e. Panel C: * p < 0.0001 vs. glimepiride; ** p < 0.05 vs. glimepiride.
    Proc Mixed Procedure With Repeated Statement From Sas Version 9.1.3, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mixed+procedure+from+sas+%28proc+mixed%29/pmc03084519-99-10-19?v=SAS+institute
    Average 90 stars, based on 1 article reviews
    proc mixed procedure with repeated statement from sas version 9.1.3 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    HbA1c over time. (A) Two-year completer population, observed mean values, no imputation. (B) Intention-to-treat (ITT) population, observed mean values, no imputation. (C) ITT population, estimated least square (LS) mean values derived from an analysis of covariance ( ancova ) model with repeated measures. (D) Two-year completer population, participants previously treated with diet and exercise, observed mean values, no imputation. Error bars are ±2s.e. Panel C: * p < 0.0001 vs. glimepiride; ** p < 0.05 vs. glimepiride.

    Journal: Diabetes, Obesity & Metabolism

    Article Title: Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

    doi: 10.1111/j.1463-1326.2010.01356.x

    Figure Lengend Snippet: HbA1c over time. (A) Two-year completer population, observed mean values, no imputation. (B) Intention-to-treat (ITT) population, observed mean values, no imputation. (C) ITT population, estimated least square (LS) mean values derived from an analysis of covariance ( ancova ) model with repeated measures. (D) Two-year completer population, participants previously treated with diet and exercise, observed mean values, no imputation. Error bars are ±2s.e. Panel C: * p < 0.0001 vs. glimepiride; ** p < 0.05 vs. glimepiride.

    Article Snippet: In addition, post-baseline estimates and treatment comparisons were obtained using repeated-measures ancova [Proc Mixed procedure with repeated statement from sas version 9.1.3 ( sas Institute, Cary, NC, USA)].

    Techniques: Derivative Assay

    Additional efficacy endpoints for 2-year completers. (A) Percentage of participants treated to HbA1c targets <7% (<53 mmol/mol) (left graph) and ≤6.5% (≤48 mmol/mol) (right graph) at 2 years. (B) Fasting plasma glucose (FPG) (mmol/l) over time. (C) Change in FPG (mmol/l) from baseline to week 104. (D) Body weight (kg) over time. (E) Change in body weight (kg) from baseline to week 104. Data in panel A are estimated percentages from a logistic regression model. Data in panels B and D are observed means. Data in panels C and E are least square (LS) means from an analysis of covariance ( ancova ) model. Error bars are ±2s.e. ETD = estimated treatment difference (liraglutide–glimepiride).

    Journal: Diabetes, Obesity & Metabolism

    Article Title: Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

    doi: 10.1111/j.1463-1326.2010.01356.x

    Figure Lengend Snippet: Additional efficacy endpoints for 2-year completers. (A) Percentage of participants treated to HbA1c targets <7% (<53 mmol/mol) (left graph) and ≤6.5% (≤48 mmol/mol) (right graph) at 2 years. (B) Fasting plasma glucose (FPG) (mmol/l) over time. (C) Change in FPG (mmol/l) from baseline to week 104. (D) Body weight (kg) over time. (E) Change in body weight (kg) from baseline to week 104. Data in panel A are estimated percentages from a logistic regression model. Data in panels B and D are observed means. Data in panels C and E are least square (LS) means from an analysis of covariance ( ancova ) model. Error bars are ±2s.e. ETD = estimated treatment difference (liraglutide–glimepiride).

    Article Snippet: In addition, post-baseline estimates and treatment comparisons were obtained using repeated-measures ancova [Proc Mixed procedure with repeated statement from sas version 9.1.3 ( sas Institute, Cary, NC, USA)].

    Techniques: Clinical Proteomics